Expression of β-dystroglycan is reduced or absent in many human carcinomas

Histopathology

Volumn 53, Issue 5, 2008, Pages 561-566

  Cross, S S ^a   Lippitt, J ^a   Mitchell, A ^a   Hollingsbury, F ^a   Balasubramanian, S P ^a   Reed, M W R ^a   Eaton, C ^a   Catto, J W ^a   Hamdy, F ^a   Winder, S J ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Cancer; Carcinoma; Cell adhesion; Dystroglycan

Indexed keywords

BETA DYSTROGLYCAN;

ARTICLE; BASEMENT MEMBRANE; BREAST CANCER; CANCER GRADING; CELL JUNCTION; COLON CANCER; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE MICROARRAY;

CARCINOMA; CELL LINE, TUMOR; DYSTROGLYCANS; EPITHELIUM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MODELS, BIOLOGICAL; TISSUE ARRAY ANALYSIS;

EID: 54949138446     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2008.03157.x     Document Type: Article

References (18)

1. Ibraghimov-Beskrovnaya O, Ervasti JM, Leveille CJ, Slaughter CA, Sernett SW, Campbell KP. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 1992 355 696 702.
2. Batchelor C, Winder SJ. Sparks, signals and shock absorbers: how dystrophin loss causes muscular dystrophy. Trends Cell Biol. 2006 16 198 205.
3. Winder SJ. The complexities of dystroglycan. Trends Biochem. Sci. 2001 26 118 124.
4. Sgambato A, Brancaccio A. The dystroglycan complex: from biology to cancer. J. Cell. Physiol. 2005 205 163 169.
5. Brennan PA, Jing J, Ethunandan M, Górecki D. Dystroglycan complex in cancer. Eur. J. Surg. Oncol. 2004 30 589 592.
6. Weir ML, Muschler J. Dystroglycan: emerging roles in mammary gland function. J. Mammary Gland Biol. Neoplasia 2003 8 409 419.
7. Martin LT, Glass M, Dosunmu E, Martin PT. Altered expression of natively glycosylated alpha dystroglycan in pediatric solid tumors. Hum. Pathol. 2007 38 1657 1668.
8. Sgambato A, De Paola B, Migaldi M et al. Dystroglycan expression is reduced during prostate tumorigenesis and is regulated by androgens in prostate cancer cells. J. Cell. Physiol. 2007 213 528 539.
9. Sgambato A, Tarquini E, Resci F et al. Aberrant expression of alpha-dystroglycan in cervical and vulvar cancer. Gynecol. Oncol. 2006 103 397 404.
10. Sgambato A, Migaldi M, Montanari M et al. Dystroglycan expression is frequently reduced in human breast and colon cancers and is associated with tumor progression. Am. J. Pathol. 2003 162 849 860.
11. Calogero A, Pavoni E, Gramaglia T et al. Altered expression of alpha-dystroglycan subunit in human gliomas. Cancer Biol. Ther. 2006 5 441 448.
12. Jing J, Lien CF, Sharma S, Rice J, Brennan PA, Górecki DC. Aberrant expression, processing and degradation of dystroglycan in squamous cell carcinomas. Eur. J. Cancer 2004 40 2143 2151.
13. Muschler J, Levy D, Boudreau R, Henry M, Campbell K, Bissell MJ. A role for dystroglycan in epithelial polarization: loss of function in breast tumor cells. Cancer Res. 2002 62 7102 7109.
14. Sgambato A, Di Salvatore MA, De Paola B et al. Analysis of dystroglycan regulation and functions in mouse mammary epithelial cells and implications for mammary tumorigenesis. J. Cell. Physiol. 2006 207 520 529.
15. Sgambato A, Camerini A, Faraglia B et al. Increased expression of dystroglycan inhibits the growth and tumorigenicity of human mammary epithelial cells. Cancer Biol. Ther. 2004 3 967 975.
16. Henry MD, Cohen MB, Campbell KP. Reduced expression of dystroglycan in breast and prostate cancer. Hum. Pathol. 2001 32 791 795.
17. Singh J, Itahana Y, Knight-Krajewski S et al. Proteolytic enzymes and altered glycosylation modulate dystroglycan function in carcinoma cells. Cancer Res. 2004 64 6152 6159.
18. Yamada H, Saito F, Fukuta-Ohi H et al. Processing of β-dystroglycan by matrix metalloproteinase disrupts the link between the extracellular matrix and cell membrane via the dystroglycan complex. Hum. Mol. Genet. 2001 10 1563 1569.